Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07747402Phase 4Not yet recruiting
A Phase 4 trial of insulin icodec in type 2 diabetes mellitus (T2DM), sponsored by Xi'an International Medical Center Hospital. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07747402.